Skip to content
Patients
Patients
Which PC Marker is right for you?
Know Your Risk
ProstateNext
ProstateNext Results
Myriad MyRisk
Myriad MyRisk Results
The One Score You Need to Know
Know Your Risk Flyer
Know Your Risk Quiz
Prostate Cancer Screening Tests
Select MDx
SelectMDx Results
4Kscore
4Kscore Results
phi
Phi Results
ExoDx
ExoDx Results
Myriad MyRisk
Myriad MyRisk Results
ProstateNext
ProstateNext Results
MyProstateScore 2.0 (MPS2)
MPS2 Results
After a Biopsy
Confirm MDx
Confirm MDx Results
Decipher
Decipher Results
Prolaris Score
Prolaris Results
Genomic Prostate Score
Genomic Prostate Score Results
Prostate Cancer Treatment
Decipher RP
Decipher RP Results
AR-V7
AR-V7 Results
Recurrence
Myriad MyRisk
Myriad MyRisk Results
ProstateNext
ProstateNext Results
Prostate Cancer Blog
Providers
Providers
Improving Early Detection
Provider PC Biomarker Guide
ProstateNext
Myriad MyRisk
Select MDx
ExoDx
4Kscore
phi test
MyProstateScore 2.0 (MPS2)
Confirm mdx
Decipher
Prolaris
Genomic Prostate Score
Decipher RP
AR-V7
Order Tests
Provider Resources
Provider Blog
About Us
Who We Are
E. David Crawford, MD.
Advisory Board
Search for:
Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer
Hmmm. No modules added.
